Publicacións en colaboración con investigadores/as de Imperial College Healthcare NHS Trust (1)

2016

  1. Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)

    Antiviral Therapy, Vol. 21, Núm. 3, pp. 195-205